Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients

Liver Transplantation

Volumn 17, Issue 8, 2011, Pages 914-920

  Haller, Wolfram ^a,b   Buttery, Jim ^b,c,d,e,f   Laurie, Karen ^g   Beyerle, Kathe ^a   Hardikar, Winita ^a,b,h   Alex, George ^a,b  

^a Department of Gastroenterology and Clinical Nutrition ^*  (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c Infectious Diseases Unit   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e MONASH CHILDREN S HOSPITAL   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INFLUENZA VACCINE; PANVAX; UNCLASSIFIED DRUG;

AGE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUSTRALIA; CHILD; CLINICAL ARTICLE; FEMALE; HEMAGGLUTINATION; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; PANDEMIC; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; SEROCONVERSION; SINGLE DRUG DOSE;

ADOLESCENT; CHILD; COHORT STUDIES; FEMALE; HUMANS; IMMUNE SYSTEM; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PANDEMICS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VACCINATION;

EID: 79960760988     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22283     Document Type: Article

References (31)

1. Vilchez RA, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, Kusne S. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287-291. (Pubitemid 36330248)
2. Ison MG,. Influenza, including the novel H1N1, in organ transplant patients. Curr Opin Infect Dis 2010; 23: 365-373.
3. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361: 2414-2423.
4. Arguedas A, Soley C, Lindert K,. Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. N Engl J Med 2010; 362: 370-372.
5. American Academy of Pediatrics Committee on Infectious Diseases. Policy statement - recommendations for prevention and control of influenza in children, 2010-2011. Pediatrics 2010; 126: 816-826.
6. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59: 1-62.
7. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10: 521-526.
8. Low CY, Kee T, Chan KP, Oon LL, Tan CK, Tee NW, Tan BH. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation 2010; 90: 1016-1021.
9. Lapinsky SE,. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010; 38 (suppl): e52-e57.
10. Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010; 60: 257-263.
11. Hajjar LA, Mauad T, Galas FR, Kumar A, da Silva LF, Dolhnikoff M, et al. Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol 2010; 21: 2333-2341.
12. Victoria Department of Health. Panvax H1N1 vaccine - guidelines for administration, December 2009. Accessed February 2011.
13. Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, Koh GC, et al. 2009 influenza A (H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010; 303: 1383-1391.
14. McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, et al. Seroprevalence of 2009 pandemic influenza A (H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill 2010; 15: 1-8.
15. Potter CW, Oxford JS,. Determinants of immunity to influenza infection in man. Br Med Bull 1979; 35: 69-75. (Pubitemid 9096975)
16. Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, Plummer F. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182: 257-264.
17. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009; 302: 1896-1902.
18. Dohna-Schwake C, Schweiger B, Felderhoff-Muser U, Fiedler M, Kaiser GM, Paul A, et al. Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications. Transplantation 2010; 90: 223-224.
19. Smud A, Nagel CB, Madsen E, Rial Mdel C, Barcán LA, Gomez AA, Martinoia AG, Bangher MC, Altclas JD, Salgueira CC, Temporiti E, Bonvehi PE, Enriquez N, Efron ED, Bibolini JE, Lattes R,. Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 2010; 90: 1458-1462.
20. Webb SA, Seppelt IM,; ANZIC Influenza Investigators. Pandemic (H1N1) 2009 influenza ("swine flu") in Australian and New Zealand intensive care. Crit Care Resusc 2009; 11: 170-172.
21. Ridao-Cano N, Sanchez-Fructuoso AI, Rodriguez-Moreno A, Barrientos A,. H1N1 2009 influenza in kidney transplant patients. Transplantation 2010; 90: 224-225.
22. Kunisaki KM, Janoff EN,. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 493-504.
23. Kumar D, Morris MI, Kotton CN, Fischer SA, Michaels MG, Allen U, Blumberg EA, Green M, Humar A, Ison MG,; AST Infectious Diseases Community of Practice and Transplant Infectious Diseases Section of TTS. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010; 10: 18-25.
24. Green M, Allen U,. H1N1 influenza A 2009 and pediatric transplantation: lessons learned and to be learned. Pediatr Transplant 2010; 14: 1-5.
25. Gaeta GB, Pariani E, Amendola A, Brancaccio G, Cuomo G, Stornaiuolo G, et al. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine 2009; 27: 3373-3375.
26. Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR,. Seroprotective titers against 2009-H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011; 17: 434-438.
27. Mack DR, Chartrand SA, Ruby EI, Antonson DL, Shaw BW Jr, Heffron TG,. Influenza vaccination following liver transplantation in children. Liver Transpl Surg 1996; 2: 431-437. (Pubitemid 26386862)
28. Gotoh K, Ito Y, Suzuki E, Kaneko K, Kiuchi T, Ando H, Kimura H,. Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons. Pediatr Transplant 2011; 15: 112-116.
29. Madan RP, Tan M, Fernandez-Sesma A, Moran TM, Emre S, Campbell A, Herold BC,. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008; 46: 712-718. (Pubitemid 351321555)
30. Sallusto F, Lanzavecchia A, Araki K, Ahmed R,. From vaccines to memory and back. Immunity 2010; 33: 451-463.
31. Dowse GK, Smith DW, Kelly H, Barr I, Laurie KL, Jones AR, et al. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study. Med J Aust 2011; 194: 68-72.